EDGAR Filing Documents for 0001564590-20-000651

Form 8-K - Current report:

SEC Accession No. 0001564590-20-000651

Filing Date

2020-01-09

Accepted

2020-01-09 16:59:25

Documents

Period of Report

2020-01-09

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	arav-8k_20200109.htm	8-K	119315
2	EX-10.1	arav-ex101_8.htm	EX-10.1	384749
3	EX-10.3	arav-ex103_6.htm	EX-10.3	127623
4	EX-10.4	arav-ex104_7.htm	EX-10.4	119509
5	EX-99.1	arav-ex991_75.htm	EX-99.1	13962
6	GRAPHIC	gkquiam1llm2000001.jpg	GRAPHIC	6820
	Complete submission text file	0001564590-20-000651.txt		776024

Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098

Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910

Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 20518691
SIC: 2834 Pharmaceutical Preparations